Aqua Bio Technology Asa: Large Shareholder Disclosure

Reference is made to the stock exchange notice of Aqua Bio Technology ASA ("ABT" or the "Company") published on 28 August 2019 regarding exercise of warrants by certain primary insiders.

As set out in that primary insider notice, Chairman of the Board Edvard Cock (through Blixen Invest AS) exercised 500,000 warrants and Board member Roger Hofseth (through Finnvik Eiendom AS) exercised 1,500,000 warrants. Upon such exercise and following expiry of the exercise period for the warrants, both Blixen Invest AS and Finnvik Eiendom AS surpassed thresholds for mandatory notification of ownership:

• Blixen Invest AS will receive 500,000 new shares in the Company following exercise of warrants. Prior to such exercise, Blixen Invest AS hold 500,000 shares and votes in the Company, corresponding to 4.25% of the shares and votes outstanding in the Company as of today. Following such exercise, Blixen Invest AS will hold 1,000,000 shares and votes in the Company corresponding to 6.5% of the total outstanding shares and votes in the Company (calculated after issuance of the new shares after exercise of warrants).
  
   
• Finnvik Eiendom AS will receive 1,500,000 new shares in the Company following exercise of warrants. Prior to such exercise, Finnvik Eiendom AS hold 2,187,000 shares and votes in the Company, corresponding to 18.79% of the shares and votes outstanding in the Company as of today. Following such exercise, Finnvik Eiendom AS will hold 3,687,000 shares and votes in the Company corresponding to 23.99% of the total outstanding shares and votes in the Company (calculated after issuance of the new shares after exercise of warrants).

             

This information is subject to the disclosure requirements pursuant to sections 4-3 and 5-12 of the Norwegian Securities Trading Act.